Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Filings indexed 524 across all filing types
Latest filing 2008-03-04 Regulatory Filings
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2008
Regulatory Filings Classification · 92% confidence The document is a press release dated February 5, 2008, announcing the two-year extension of a 'Molecular Imaging Development Agreement' between Biotage AB and McMaster University. It details research progress, technological benefits (microwave synthesis, chromatography), and future plans regarding radionuclides and PET imaging agents. This type of announcement, focusing on a specific research collaboration, partnership extension, or scientific development outcome, does not fit neatly into standard financial reporting categories like 10-K, ER, or IR. It is an announcement related to business development and scientific progress, which is often categorized under general regulatory announcements or investor relations updates. Given the options, 'Regulatory Filings' (RNS) serves as the best general category for non-standard, material business announcements that aren't explicitly covered by other codes (like M&A, Capital Change, or Director Dealing). It is not a formal financial report, earnings release, or management discussion.
2008-03-04 English
Regulatory Filings 2008
Regulatory Filings Classification · 90% confidence The document is explicitly titled "Press release" and announces a business development event: the extension of a collaboration agreement between Biotage and McMaster University regarding Molecular Imaging research. It details the success of the initial phase and the plans for the next two years. This type of announcement, focusing on strategic partnerships, research outcomes, and business development milestones, is characteristic of a general corporate announcement rather than a formal regulatory filing (like 10-K, IR, or ER). Since it is a press release detailing a strategic business development, it does not fit perfectly into the highly specific categories like Capital/Financing (CAP), M&A (TAR), or Director's Dealing (DIRS). It is a general corporate update. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for general, non-standardized corporate news releases that don't fit the other specific categories, although 'RPA' (Report Publication Announcement) is sometimes used for press releases announcing reports. Since this is an announcement of an agreement extension, not the publication of a formal financial report, RNS serves as the best general category for non-standard corporate news.
2008-03-04 Swedish
Annual Report 2007
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2007' (Annual Report 2007) and contains comprehensive financial statements, including balance sheets, income statements, cash flow analyses, and notes for both the group and the parent company. It also includes a management report ('Förvaltningsberättelse'), auditor's report ('Revisionsberättelse'), and board information. This matches the definition of an Annual Report (10-K). FY 2007
2008-03-01 Swedish
Environmental & Social Information 2008
Environmental & Social Information Classification · 99% confidence The document is a press release dated February 19, 2008, announcing a strategic shift by Biotage AB to increase focus on environmental market segments, mentioning new product development and existing product lines relevant to environmental analysis (like SPE sorbents for water contaminants). This content relates to the company's operational strategy and its focus areas, which aligns best with general corporate reporting or strategic updates. Since it is not a formal financial report (10-K, IR, ER), a management discussion (MDA), or a specific regulatory filing, and it discusses ESG-related topics (environmental focus), the closest fit among the provided codes is Environmental & Social Information (SR), although it is more of a strategic announcement than a formal ESG report. However, given the content is a strategic announcement about focusing on environmental analysis, it touches upon the 'Social' or 'Environmental' aspect of ESG. If a more general strategic announcement code existed, it would fit there. Given the options, SR is the most relevant category touching upon environmental performance focus, even if it's a strategic press release rather than a formal SR report.
2008-02-19 English
Environmental & Social Information 2008
Environmental & Social Information Classification · 99% confidence The document is a short press release dated February 19, 2008, from Biotage AB. The content focuses on the company's strategic decision to increase focus on the environmental analysis segment, mentioning new product launches (EVOLUTE ABN 50 µm) and the importance of environmental monitoring (EPH in soil and water). This type of announcement, detailing strategic direction, product focus, and general business updates outside of specific financial reporting periods (like earnings or annual reports), best fits the category for Environmental & Social Information (ESG focus) or potentially a general Regulatory Filing (RNS). Since the core theme is explicitly about environmental market focus and product relevance to environmental analysis, the 'Environmental & Social Information' (SR) code is the most appropriate fit, as ESG reporting often includes operational focus areas related to environmental impact and solutions. It is not a formal financial report (10-K, IR, ER) nor a management discussion (MDA). Given the strong emphasis on environmental market strategy, SR is selected over the general RNS fallback.
2008-02-19 Swedish
Earnings Release 2007
Earnings Release Classification · 98% confidence The document is titled "Bokslutskommuniké för 2007" (Year-end report communication for 2007) and contains detailed financial results for the full year 2007 and the fourth quarter, including income statements, balance sheet items, segment reporting (Discovery Chemistry and Biosystems), and commentary from the CEO. This structure and content strongly indicate a comprehensive annual financial report, even though the title uses the term 'Kommuniké' (Communication). Given the extensive nature of the financial data provided (over 80,000 characters, though truncated here, the provided text is substantial and detailed), it functions as the primary annual financial disclosure. In the context of US SEC filings, this aligns most closely with the content of a 10-K, which is the official yearly report covering full financial performance. Since the provided definitions do not have a specific code for a non-US 'Year-End Report' that isn't explicitly a 10-K, and this document contains the full annual performance review, '10-K' is the most appropriate classification for a comprehensive annual financial report. FY 2007
2008-02-07 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.